Mark Magdi Awad

39PUBLICATIONS

445CO-AUTHORS

Predictive and prognostic markersMolecular targetsHaematological tumoursInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (39)

Sort by Publication Date:

|Jul 14, 2026

Clinical significance of EGFR amplification in patients with EGFR-mutated metastatic non-small cell lung cancer receiving first-line osimertinib.

|Jun 22, 2026

EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway.

|May 18, 2026

Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with NSCLC without actionable genomic alterations who never used tobacco.

|May 05, 2026

Metastatic Trajectories in Non-Small Cell Lung Cancer Guide Local and Systemic Therapies.

|Feb 23, 2026

Evolution of oncogene amplification across 86,000 cancer cell genomes.

Jake June-Koo Lee, Sohrab Salehi, Matthew A Myers

|Feb 04, 2026

Kras G12C- and G12D-driven lung cancers differ in oncogenic potency, immunogenicity, and relapse after Kras inhibition in mouse models.

Hai-Cheng Huang, Qing Deng, Lei Guo

Pageof 7

Frequent Collaborators

26 joint publications

Biagio Ricciuti

19 joint publications

Joao Victor Alessi

13 joint publications

Alessandro Di Federico

11 joint publications

Lynette Sholl

10 joint publications

Mizuki Nishino

Federica Pecci

Malini M Gandhi

Giuseppe Lamberti

Adam Schoenfeld

Xinan Wang

Frequent Collaborators

26 joint publications

Biagio Ricciuti

19 joint publications

Joao Victor Alessi

13 joint publications

Alessandro Di Federico

11 joint publications

Lynette Sholl